Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.53B |
| 2 |
Procter & Gamble
PG
|
+$1.01B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$684M |
| 4 |
Zoom
ZM
|
+$534M |
| 5 |
Chewy
CHWY
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.07B |
| 2 |
ServiceNow
NOW
|
+$874M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$776M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$767M |
| 5 |
Apple
AAPL
|
+$719M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.32% |
| 2 | Healthcare | 10.4% |
| 3 | Consumer Discretionary | 8.1% |
| 4 | Communication Services | 7.82% |
| 5 | Financials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
B
2226
DELISTED
Barnes Group Inc.
B
| $7.47M | ﹤0.01% |
188,841
+30,941
| +20% | +$1.19M |
|
2227
Ralph Lauren
RL
$22.5B
| $7.47M | ﹤0.01% |
102,995
+12,071
| +13% | +$888K |
|
2228
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.6B
| $7.46M | ﹤0.01% |
280,613
+80,522
| +40% | +$1.98M |
|
2229
PTC
PTC
$15.4B
| $7.46M | ﹤0.01% |
95,840
+10,034
| +12% | +$711K |
|
2230
Goldman Sachs ActiveBeta Japan Equity ETF
GSJY
$86.1M
| $7.45M | ﹤0.01% |
241,074
-17,414
| -7% | -$518K |
|
|
CNH
2231
CNH Industrial
CNH
$13.9B
| $7.44M | ﹤0.01% |
1,215,613
-3,377,887
| -74% | -$18.7M |
|
2232
Invesco Dorsey Wright Developed Markets Momentum ETF
PIZ
$753M
| $7.42M | ﹤0.01% |
268,584
-29,840
| -10% | -$760K |
|
|
MEET
2233
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $7.42M | ﹤0.01% |
1,189,122
+150,380
| +14% | +$926K |
|
|
MIC
2234
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $7.42M | ﹤0.01% |
241,637
-298,225
| -55% | -$8.25M |
|
2235
Acuity Brands
AYI
$10.4B
| $7.41M | ﹤0.01% |
77,420
+15,392
| +25% | +$1.35M |
|
2236
BlackBerry
BB
$5.2B
| $7.41M | ﹤0.01% |
1,515,807
+877,748
| +138% | +$3.97M |
|
2237
TripAdvisor
TRIP
$1.67B
| $7.41M | ﹤0.01% |
389,709
+32,938
| +9% | +$629K |
|
|
LMNX
2238
DELISTED
Luminex Corp
LMNX
| $7.41M | ﹤0.01% |
227,713
+59,772
| +36% | +$1.89M |
|
2239
Inovio Pharmaceuticals
INO
$68.5M
| $7.41M | ﹤0.01% |
22,896
+3,833
| +20% | +$615K |
|
2240
First Trust RBA American Industrial Renaissance ETF
AIRR
$10.6B
| $7.38M | ﹤0.01% |
304,778
+30,647
| +11% | +$674K |
|
2241
Live Nation Entertainment
LYV
$42.8B
| $7.38M | ﹤0.01% |
166,455
+46,399
| +39% | +$2.03M |
|
2242
Ultragenyx Pharmaceutical
RARE
$2.54B
| $7.38M | ﹤0.01% |
94,303
+13,688
| +17% | +$906K |
|
2243
Wendy's
WEN
$1.46B
| $7.37M | ﹤0.01% |
338,327
-2,353
| -0.7% | -$46.8K |
|
2244
Silicon Laboratories
SLAB
$7.2B
| $7.34M | ﹤0.01% |
73,251
+29,077
| +66% | +$2.72M |
|
2245
Mueller Water Products
MWA
$4.16B
| $7.34M | ﹤0.01% |
778,455
+15,017
| +2% | +$134K |
|
2246
VanEck Short Muni ETF
SMB
$311M
| $7.32M | ﹤0.01% |
406,193
-5,598
| -1% | -$99.4K |
|
2247
Merit Medical Systems
MMSI
$5.12B
| $7.31M | ﹤0.01% |
160,216
+10,290
| +7% | +$415K |
|
|
BSJN
2248
DELISTED
Invesco BulletShares 2023 High Yield Corporate Bond ETF
BSJN
| $7.31M | ﹤0.01% |
304,888
+5,513
| +2% | +$129K |
|
2249
TRI-Continental Corp
TY
$1.9B
| $7.3M | ﹤0.01% |
295,558
+38,324
| +15% | +$905K |
|
2250
iShares MSCI Poland ETF
EPOL
$754M
| $7.3M | ﹤0.01% |
439,282
+250,157
| +132% | +$3.89M |
|
Similar funds
Morgan Stanley's Q2 2020 Portfolio in Review
As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
- Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
- Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
- Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
- Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
- Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
- Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.
Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.